Correlation Between Centessa Pharmaceuticals and Mars Acquisition

Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Mars Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Mars Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Mars Acquisition Corp, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Mars Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Mars Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Mars Acquisition.

Diversification Opportunities for Centessa Pharmaceuticals and Mars Acquisition

-0.31

Correlation Coefficient

Centessa Pharmaceuticals  Mars Acquisition

Very good diversification

The 3 months correlation between Centessa and Mars is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Mars Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mars Acquisition Corp and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Mars Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mars Acquisition Corp has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Mars Acquisition go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Mars Acquisition

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 1.91 times more return on investment than Mars Acquisition. However, Centessa Pharmaceuticals is 1.91 times more volatile than Mars Acquisition Corp. It trades about 0.1 of its potential returns per unit of risk. Mars Acquisition Corp is currently generating about -0.01 per unit of risk. If you would invest  319.00  in Centessa Pharmaceuticals PLC on September 30, 2024 and sell it today you would earn a total of  1,376  from holding Centessa Pharmaceuticals PLC or generate 431.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.17%
Values	Daily Returns

Centessa Pharmaceuticals PLC  vs.  Mars Acquisition Corp

Centessa Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Centessa Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Mars Acquisition Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mars Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Centessa Pharmaceuticals and Mars Acquisition

The main advantage of trading using opposite Centessa Pharmaceuticals and Mars Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Mars Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mars Acquisition will offset losses from the drop in Mars Acquisition's long position.

The idea behind Centessa Pharmaceuticals PLC and Mars Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.